Estimating and comparing cancer progression risks under varying surveillance protocols

DOI10.1214/17-AOAS1130MaRDI QIDQ1621032zbMATH OpenOpenAlexWikidataFDO

Authors Jane M. Lange, Roman Gulati, Amy S. Leonardson, Daniel W. Lin, Lisa F. Newcomb, Bruce J. Trock, H. Ballentine Carter, Peter R. Carroll, Matthew R. Cooperberg, Janet E. Cowan, Lawrence H. Klotz, Ruth Etzioni

Publication date 15 November 2018

Published in The Annals of Applied Statistics (Search for Journal in Brave)

Full work available at URL https://projecteuclid.org/euclid.aoas/1536652974

zbMATH Keywords

active surveillancehidden Markov modelmultistate modelpanel dataprostate cancer

Mathematics Subject Classification ID

Markov processes: estimation; hidden Markov models (62M05) Reliability and life testing (62N05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Probability modeling and statistical inference in periodic cancer screening
• Bounds in Competing Risks Models and the War on Cancer
• A stochastic model for calibrating the survival benefit of screen-detected cancers
• Proportional Hazards Regression for Cancer Studies
• Estimating lifetime and age-conditional probabilities of developing cancer
• Estimating multiple tumor transition rates based on data from survival- sacrifice experiments
• Calibrating disease progression models using population data: a critical precursor to policy development in cancer control

Cites work

• A frailty model for informative censoring
• A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data
• A Maximization Technique Occurring in the Statistical Analysis of Probabilistic Functions of Markov Chains
• Estimating disease progression using panel data
• Joint latent class model for longitudinal data and interval-censored semi-competing events: application to dementia
• Multi-state models for event history analysis
• Nineteen Dubious Ways to Compute the Exponential of a Matrix, Twenty-Five Years Later
• Nonparametric Estimation in a Markov “Illness–Death” Process from Interval Censored Observations with Missing Intermediate Transition Status
• Nonparametric Maximum Likelihood Estimation for Competing Risks Survival Data Subject to Interval Censoring and Truncation
• Semi-Markov Models with Phase-Type Sojourn Distributions
• Semiparametric Regression Analysis of Interval-Censored Competing Risks Data
• Statistical Inference for Discretely Observed Markov Jump Processes
• Statistical methods for panel data from a semi-Markov process, with application to HPV

Cited in

(7)

• A stochastic approach to risk management for prostate cancer patients on active surveillance
• Bayesian inference for continuous-time hidden Markov models with an unknown number of states
• Personalized schedules for surveillance of low-risk prostate cancer patients
• Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II
• Tailored optimal posttreatment surveillance for cancer recurrence
• A Bayesian accelerated failure time model for interval censored three-state screening outcomes
• The heterogeneity effect of surveillance intervals on progression free survival

This page was built for publication: Estimating and comparing cancer progression risks under varying surveillance protocols

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1621032)